Discover 585 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 585
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
for
Non-small Cell Lung Cancer
Location: Richmond VA, Fairfax VA, Washington D.C. DC,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712316
Phase 2, Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Richmond VA, Charlottesville VA, Gainesville VA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase 3, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Richmond VA, Fairfax VA, Arlington VA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase 3, Recruiting
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Richmond VA, Baltimore MD, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03606967
Phase 2, Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Richmond VA, Washington D.C. DC, Rockville MD,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06585410
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
for
Rectal Cancer
Location: Richmond VA, South Hill VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18+
Code: NCT04643366
Phase 2, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Richmond VA, Washington D.C. DC, Baltimore MD,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase 3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Richmond VA, Charlottesville VA, Norfolk VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
for
Endometrial Cancer, Cervical Cancer,
Location: Richmond VA, Howard Beach NY, Westbury NY, Cleveland OH,
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT05051722
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Richmond VA, Mechanicsville VA, Midlothian VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06770582
Phase 2, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Richmond VA, Arlington VA, Frederick MD, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Richmond VA, Chapel Hill NC, Pittsburgh PA, Detroit MI,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06295731
Phase 2, Phase 3, Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
for
Malignant Digestive System Neoplasm,
Location: Richmond VA, Elkton MD, Newark DE, Winston-Salem NC,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT07215624
Recruiting
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Richmond VA, Winston-Salem NC, Concord NC, Charlotte NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06661915
Phase 2, Recruiting
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
for
Acute Adult T-Cell Leukemia/Lymphoma,
Location: Richmond VA, Basking Ridge NJ, Middletown NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04301076
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Richmond VA, Winston-Salem NC, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase 1, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: Richmond VA, Durham NC, Newark DE, Chadds Ford PA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase 3, Recruiting
Family Communications After Genetic Testing
for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Richmond VA, South Hill VA, Randallstown MD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07143487
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Richmond VA, Easton MD, Glen Burnie MD, Columbia MD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase 3, Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Richmond VA, Mechanicsville VA, Midlothian VA,